Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
about
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part IImmunosuppression for heart transplantation: where are we now?The first year post-heart transplantation: use of immunosuppressive drugs and early complications.Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
P2860
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@ast
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@en
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@nl
type
label
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@ast
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@en
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@nl
prefLabel
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@ast
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@en
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@nl
P2093
P1476
Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
@en
P2093
P304
P356
10.1016/S1053-2498(00)00222-9
P577
2001-07-01T00:00:00Z